Management Team

Laura A. Francis has served as our Chief Executive Officer and a Director on our Board since April 2021.  As our Chief Financial Officer since May 2015 and Chief Operating Officer since July 2019, Ms. Francis played a fundamental role in bringing the company public in October 2018 and building the

Anshul Maheshwari has served as Chief Operating Officer and Chief Financial Officer of SI-BONE since February 2026. In this role, he oversees Finance, Investor Relations, Global Operations, Information Technology, and Project Management. He joined SI-BONE in 2021 as Chief Financial Officer and took

Nikolas F. Kerr has served as Chief Commercial Officer since February 2026. He joined the company in 2016 as Vice President of Product Management and later became Senior Vice President of Product and Marketing beginning in 2021. Before joining the company, he led Kerr Consulting Group, advising

Michael A. Pisetsky was named Chief Business & Legal Affairs Officer in April 2023. In this role, Mr. Pisetsky leads all aspects of SI-BONE’s supply chain and customer service operations, as well as its Legal, Quality Assurance, Program Management, IT and other administrative support organizations,

Daniel J. Cher, MD was named Senior Vice President Clinical, Regulatory Affairs and Quality in June 2021. Dr. Cher has served as our Vice President, Clinical Affairs since January 2012. From May 2008 to December 2011, Dr. Cher served as Vice President of Clinical and Regulatory Affairs at Chestnut

W. Carlton Reckling, MD has served as our Vice President, Medical Affairs since April 2012 and our Chief Medical Officer since February 2017. From July 1994 to April 2012, Dr. Reckling was a spine surgeon at the Spine Center in Loveland, Colorado, Rocky Mountain Orthopedic Specialists in Cheyenne,

Scott A. Yerby, PhD was named Senior Vice President of Engineering & Chief Technology Officer by SI-BONE in April 2021.  In this role, Dr. Yerby is responsible for developing and bringing to market innovative solutions that help treat sacropelvic conditions. Prior to SI-BONE, Dr.

Jeffrey D. Zigler was named Senior Vice President, Market Access and Reimbursement in February 2026. He joined SI‑BONE in 2019 as Vice President, Market Access and Reimbursement. Prior to SI‑BONE, Mr. Zigler led Reimbursement and Health Economics at LDR Spine through its acquisition by Zimmer

Ian Bailey was named Vice President of Product and Marketing in February 2026, where he leads product strategy, marketing, and market development to support growth and innovation in the marketplace. He brings over a decade of experience across sales, product management, and business strategy, with

Joyce Goto brings over 20 years of financial management and accounting experience to SI-BONE. Prior to joining SI-BONE, Ms. Goto was the chief accounting officer at BioPharmX, a public, specialty pharmaceutical company focused on dermatology indications, until its acquisition by Timber

Saqib Iqbal serves as Vice President of Financial Planning & Analysis and Investor Relations, a role he assumed in April 2025. In this capacity, he leads the company’s strategic financial planning initiatives and oversees all aspects of investor communications and capital markets engagement.

Neville Lorimer joined SI-BONE in September 2022 as Vice President, International with responsibility for EMEA, Japan and Rest of World (ROW). Mr. Lorimer is a seasoned Sales and Marketing executive with over 21 years in the healthcare industry. Prior to joining SI-BONE, Mr.

Mr. Maw joined SI-BONE in 2014 and has nearly 30 years of experience in health care sales, sales management, marketing and national accounts experience. The majority of his career has been spent working within young growth organizations that focus on building markets via transformational,

Roxanne Simon serves as Vice President of PMO and Process Improvement at SI-BONE. In this capacity, Ms. Simon provides strategic oversight of project management governance and spearheads initiatives to enhance organizational efficiency through process optimization.

Luke Smith was promoted to Vice President of U.S. Sales in August 2025, bringing nearly two decades of medical device experience and a proven record of driving growth and building high-performing teams. Since joining SI-BONE in 2014, Luke has been instrumental in shaping the company’s commercial

Ashok Srinivasan has joined SI-BONE as Vice President of Global Operations.  Ashok will oversee Field Operations and Planning, Warehouse and Distribution, Vendor Management, and Customer Service.  Ashok brings more than 22 years of experience in medical device operations, including nearly 18 years

Mike Vedda joined SI-BONE in December 2024 as Vice President of Information Technology. With more than two decades of leadership experience across healthcare, biotech, and medical device companies, Mike brings a proven track record of advancing digital capabilities to enable business growth.